Phage Therapy in Solid Organ Transplant Recipients – State of the Evidence and Future Directions
Phage Therapy in Solid Organ Transplant Recipients – State of the Evidence and Future Directions
Understand the history of bacteriophage therapy, challenges, and the current research and clinical trial landscape.
- 3:00 PM - 4:00 PM EST
- Virtual, as part of AST's T3 webinar series.
Objectives:
After participating in this webinar, the attendee will be able to:
- Describe the current experience with bacteriophage therapy (history, safety, effectiveness)
- Describe challenges in treating SOT recipients with phages, including persons with LVADs and CF
- Understand the current research and clinical trial landscape to bring phages to the mainstream
Speakers:
- Saima Aslam, MD, MS, FAST • Professor of Medicine and Clinical Lead, Center for Innovative Phage Applications and Therapeutics, University of California San Diego, La Jolla, CA
- Ghady Haidar, MD • Assistant Professor of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
Moderator:
- Raymund Razonable, MD, FAST • Professor of Medicine and Vice Chair, Infectious Diseases, Mayo Clinic College of Medicine & Science, Rochester, MN
- - - - -
The AST Education Committee would like to thank the Infectious Disease Community of Practice (IDCOP) for suggesting this topic as part of the 2023-2024 T3 webinar series. Learn more about AST's COPs at www.www.myast.org/cops .
Advertisements
This content was developed independently by AST and supported by a financial contribution from
